Our company's primary focus is the production of sustained-release formulations and ophthalmic medications for treating cardiovascular conditions. Additionally, we also specialize in raw material drugs, creating a range of products centered around sustained and controlled release preparations as well as ophthalmic medications.
Kangya of Ningxia Pharmaceutical
Headquarters
People's Republic of China